The hypercoagulability of patients with nephrotic syndrome could be an important trigger for arterial and venous thrombotic events. Arterial thromboses are less frequent than venous thromboses and the most common locations are femoral arteries. The association of stroke and nephrotic syndrome is extremely rare. Here we report the case of a patient with stroke as first manifestation of nephrotic syndrome. Ischemic stroke can be the first manifestation of nephrotic syndrome and should be considered as a possible complication of the syndrome, when the commonest causes of ischemic stroke are excluded and especially in presence of pre-existing glomerular disease.

NEPHROTIC SYNDROME AND STROKE / Gigante, Antonietta; Barbano, Biagio; Liberatori, Marta; L., Sardo; GASPERINI ZACCO, MARIA LUDOVICA; Rosato, Edoardo; Cianci, Rosario; Amoroso, Antonio. - In: INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY. - ISSN 0394-6320. - STAMPA. - 26:3(2013), pp. 769-772.

NEPHROTIC SYNDROME AND STROKE

GIGANTE, ANTONIETTA;BARBANO, BIAGIO;LIBERATORI, MARTA;GASPERINI ZACCO, MARIA LUDOVICA;ROSATO, Edoardo;CIANCI, ROSARIO;AMOROSO, Antonio
2013

Abstract

The hypercoagulability of patients with nephrotic syndrome could be an important trigger for arterial and venous thrombotic events. Arterial thromboses are less frequent than venous thromboses and the most common locations are femoral arteries. The association of stroke and nephrotic syndrome is extremely rare. Here we report the case of a patient with stroke as first manifestation of nephrotic syndrome. Ischemic stroke can be the first manifestation of nephrotic syndrome and should be considered as a possible complication of the syndrome, when the commonest causes of ischemic stroke are excluded and especially in presence of pre-existing glomerular disease.
2013
therapeutic use; male; complications/diagnosis/drug therapy; angiotensin-converting enzyme inhibitors; magnetic resonance imaging; nephrotic syndrome; treatment outcome; drug effects; humans; immunosuppressive agents; aged; diagnosis/drug therapy/etiology; stroke; arterial thrombosis; deep vein thrombosis; combination; anticoagulants; hydroxymethylglutaryl-coa reductase inhibitors; drug therapy; blood coagulation; coagulation
01 Pubblicazione su rivista::01a Articolo in rivista
NEPHROTIC SYNDROME AND STROKE / Gigante, Antonietta; Barbano, Biagio; Liberatori, Marta; L., Sardo; GASPERINI ZACCO, MARIA LUDOVICA; Rosato, Edoardo; Cianci, Rosario; Amoroso, Antonio. - In: INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY. - ISSN 0394-6320. - STAMPA. - 26:3(2013), pp. 769-772.
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/649651
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 5
social impact